(ANSA-AFP) - GENEVA, APRIL 22 - The World Health Organization "strongly recommends" the antiviral of the Pfizer group - Paxlovid - for patients "at higher risk of hospitalization" for less severe forms of Covid.
The pill from the American pharmaceutical company "is the drug of choice" for unvaccinated, elderly or immunosuppressed patients.
For the same type of patients and symptoms, WHO has issued a "weak recommendation" for Gilead, which it previously advised against.
(ANSA-AFP).
